IFORRESTINE;2-AMINO-8,9-DIHYDROOXAZOLO-[4,5-G]-PYRIDO-[2,1-C]-[1,4]-BENZODIAZEPINE-7,13(6H,7A-BETA-H)-DIONE
Compound with spectra: 1 NMR
![IFORRESTINE;2-AMINO-8,9-DIHYDROOXAZOLO-[4,5-G]-PYRIDO-[2,1-C]-[1,4]-BENZODIAZEPINE-7,13(6H,7A-BETA-H)-DIONE](/api/compound/KkVi50N48Bx.png?ph=true&h=300&w=458 "IFORRESTINE;2-AMINO-8,9-DIHYDROOXAZOLO-[4,5-G]-PYRIDO-[2,1-C]-[1,4]-BENZODIAZEPINE-7,13(6H,7A-BETA-H)-DIONE")
| SpectraBase Compound ID | KkVi50N48Bx |
|---|---|
| InChI | InChI=1S/C14H12N4O3/c15-14-17-11-9(21-14)5-4-7-10(11)13(20)18-6-2-1-3-8(18)12(19)16-7/h2,4-6,8H,1,3H2,(H2,15,17)(H,16,19)/t8-/m0/s1 |
| InChIKey | MCNNCDFRSLCHRM-QMMMGPOBSA-N |
| Mol Weight | 284.28 g/mol |
| Molecular Formula | C14H12N4O3 |
| Exact Mass | 284.09094 g/mol |
| Enantiomer InChIKey | MCNNCDFRSLCHRM-MRVPVSSYSA-N |
| Racemate InChIKey | MCNNCDFRSLCHRM-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
4-[[(DIMETHYLAMINO)-METHYLIDENE]-AMINO]-7-[3-O-[(1,1-DIMETHYLETHYL)-DIMETHYLSIL5-O-(4-METHOXYTRITYL)-BETA-D-RIBOFURANOSYL]-7H-PYRROLO-[2,3-D]-PYRIMIDINE;COMPOU
4-Fluoreno[3,4-b]benzo[b]thiophen-4-one
1H-indole-3-acetamide, N-[2-[[(2,5-dimethylphenyl)amino]carbonyl]phenyl]-1-methyl-alpha-oxo-2-phenyl-
LYJIXBRHCDGTCL-UHFFFAOYSA-N
N-N-PENTYL-5,10-DIOXO-5,10-DIHYDRO-4H-[1,4]-THIAZINO-[2,3-G]-QUINOLINE-7-CARBOXAMIDE-1,1-DIOXIDE
N-(PROP-2-YN-1-YL)-5,10-DIOXO-5,10-DIHYDRO-4H-[1,4]-THIAZINO-[2,3-G]-QUINOLINE-7-CARBOXAMIDE-1,1-DIOXIDE
Methyl 3-mesityl-4-phenyl-5-benzoylamino-2-isoxazoline-5-carboxylate
STERENIN_B
Bis(4-Oxo-2-phenylquinazolin-3(4H)-yl)phenyl phosphineoxide
Pyrrolo[1,2-a]quinazoline-1,5-dione, 3a-methyl-4-phenyl-2,3,3a,4-tetrahydro-
| Title | Journal or Book | Year |
|---|---|---|
| (+)-Iforrestine: a Novel Heterocyclic Nephrotoxin From Isotropis forrestii | Australian Journal of Chemistry | 1989 |